Share-based payment arrangements, governed by IFRS 2, are a common tool for companies to incentivize employees and executives. While the core principle involves recognizing an expense over the vesting period, the devil is often in the details, especially when dealing with complex vesting conditions. This post dives into a specific, critical aspect: accounting for non-market performance vesting conditions and the continuous process of estimating and re-estimating the probability of these conditions being met.
What are Non-Market Performance Vesting Conditions?
First, let's clarify what we mean. Non-market performance conditions are criteria for an award to vest that are based on the entity’s own operations or activities, rather than the market price of its shares. Examples include achieving specific revenue targets, profit margins, employee retention rates, or the successful completion of a project. Unlike market conditions (e.g., share price targets), the achievement of non-market conditions is within the control or influence of the entity’s management.
The Initial Probability Estimation
At the grant date of a share-based award, a company must make its best estimate of the probability that any non-market performance vesting conditions will be satisfied. This isn't a mere formality; it's fundamental to determining the initial fair value of the equity instrument for accounting purposes. For instance, if an award vests only if a specific revenue target is met, the company assesses the likelihood of hitting that target. If it's deemed highly probable, the full estimated fair value of the award (less any forfeiture rate) will begin to be expensed over the vesting period. If it's unlikely, a lower expense, or even no expense, might be recognized initially.
This initial estimation requires careful judgment, often incorporating historical performance, budgets, forecasts, and strategic plans. Actuarial expertise can be invaluable in building robust models to support these judgments, ensuring that the probability assessment is well-founded and defensible.
The Crucial Role of Re-estimation
Here’s where the accounting for non-market conditions differs significantly from market conditions. For non-market conditions, the probability estimate is not static. At each reporting date, until the vesting date, the company must re-estimate the likelihood of these conditions being met. Circumstances change, and so too should the accounting reflection of those changes.
If, at a subsequent reporting date, the probability of achieving a revenue target increases, the cumulative expense recognized to date will be adjusted upwards to reflect this new assessment. Conversely, if economic conditions worsen and the revenue target becomes less likely to be achieved, the cumulative expense will be adjusted downwards, potentially even reversing previously recognized expense. If it becomes clear that a non-market condition will *not* be met, any cumulative expense recognized for that award must be fully reversed.
Impact on Expense Recognition
The re-estimation process directly impacts the amount of share-based payment expense recognized in profit or loss for the period. Changes in the probability assessment lead to corresponding adjustments to the cumulative expense recognized over the vesting period. This dynamic adjustment ensures that the financial statements accurately reflect the company's best estimate of the ultimate outcome of the non-market performance conditions.
In essence, while the fair value of the award is determined at the grant date, the recognition of the expense related to non-market conditions is continually refined based on evolving expectations of their achievement. This ongoing assessment requires diligent monitoring, strong internal controls, and often, the specialized analytical skills that actuaries bring to the table. By meticulously estimating and re-estimating these probabilities, companies ensure their IFRS 2 accounting truly reflects the substance of their share-based payment arrangements.
Need Help With Your IFRS 2 Valuation?
Our qualified actuaries can help you with discount rate selection, assumption setting, and full IFRS 2 valuations.
Get a Quote